Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics
Authors:
- Richard F BrubakerRBRichard F Brubaker
- Erik O SchoffESErik O Schoff
- Cherie B NauCNCherie B Nau
- Susan P CarpenterSCSusan P Carpenter
- Kuankuan ChenKCKuankuan Chen
- Amanda M VandenburghAVAmanda M Vandenburgh
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 131 (1) , 19-24
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Replacement of the carboxylic acid group of prostaglandin F2α with a hydroxyl or methoxy substituent provides biologically unique compoundsBritish Journal of Pharmacology, 2000
- Comparison of the Early Effects of Brimonidine and Apraclonidine as Topical Ocular Hypotensive AgentsArchives of Ophthalmology (1950), 1999
- Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2Journal of Biological Chemistry, 1997
- Chapter 9 Clinical Measurements of Aqueous Dynamics: lmplications for Addressing Glaucoma1997
- The Effects of Sleep on Circulating Catecholamines and Aqueous Flow in Human SubjectsExperimental Eye Research, 1996
- Aqueous Humor Dynamics in Patients With Diabetes MellitusAmerican Journal of Ophthalmology, 1995
- Blood circulation and fluid dynamics in the eyePhysiological Reviews, 1975
- Abflussdruck, Minutenvolumen und Widerstand der Kammerwasser-strömung des MenschenDocumenta Ophthalmologica, 1951